Medical Cannabis for Chronic Pain: A UK Patient Guide

Chronic pain is defined as pain that lasts for more than three months. It can manifest as neuropathic pain (nerve pain), musculoskeletal pain, or widespread conditions like fibromyalgia. These conditions can be debilitating, leading to reduced mobility, sleep disturbances, and psychological distress.

Our bodies possess a complex cell-signalling system known as the endocannabinoid system (ECS). This system plays a crucial role in regulating pain, mood, sleep, and appetite. CB1 receptors are primarily found in the brain and central nervous system, influencing pain perception, while CB2 receptors are mainly located in the immune system, affecting inflammation.

Both THC and CBD contribute to the therapeutic effects of medical cannabis for pain, but through different mechanisms. THC is the primary psychoactive compound in cannabis. It directly activates CB1 receptors, which are abundant in areas of the brain and spinal cord involved in pain processing. This can lead to a reduction in pain perception and muscle spasticity.

CBD is non-psychoactive. It works more indirectly, influencing the ECS and other receptor systems to produce anti-inflammatory and analgesic effects. Many patients find CBD beneficial for pain management without the psychoactive effects associated with THC. Often, a combination of THC and CBD is used — known as the entourage effect — to enhance therapeutic outcomes.

The UK Medical Cannabis Registry — a real-world data programme tracking patient outcomes — has reported that a significant proportion of patients with chronic pain experience clinically meaningful reductions in pain scores after six months of CBPM treatment. Evidence is particularly strong for neuropathic pain, where conventional treatments often fail.

Additionally, several observational studies have found that patients who begin CBPM treatment significantly reduce their opioid consumption — an important benefit given the scale of opioid-related harm in the UK.

CBMPs are most commonly prescribed for the following chronic pain conditions in the UK: neuropathic pain (including diabetic neuropathy and post-herpetic neuralgia), fibromyalgia, musculoskeletal pain (including back pain and arthritis), multiple sclerosis spasticity, cancer-related pain, and complex regional pain syndrome (CRPS).

Eligibility requires a specialist consultation and evidence that at least two conventional treatments have been tried without adequate relief. If you have been living with chronic pain and conventional treatments have not worked, you may well be eligible for a CBPM prescription.

When you begin CBPM treatment for chronic pain, your clinician will typically start you on a low dose and titrate upwards gradually — a principle known as 'start low, go slow'. This approach minimises side effects and allows your body to adjust to the medication.

Most patients notice some improvement in pain levels within the first two to four weeks, though full therapeutic effect may take six to eight weeks to develop. Your clinician will use validated pain scoring tools (such as the Brief Pain Inventory or Numeric Rating Scale) at each follow-up to track your progress objectively.

It is important to maintain a pain diary during the early weeks of treatment, noting pain levels, sleep quality, and any side effects. This information is invaluable to your clinician when adjusting your treatment plan.

Medical cannabis is most effective when used as part of a comprehensive pain management plan. Your specialist clinician may recommend combining CBMP treatment with physiotherapy, psychological support (such as pain-focused CBT), lifestyle modifications (including exercise and sleep hygiene), and appropriate use of other medications.

Many patients find that CBMPs allow them to reduce their reliance on opioids and other analgesics, which can have significant quality-of-life benefits. However, any reduction in existing medications should always be done gradually and under medical supervision — never abruptly.

MEDCANN Pharmacy's clinical team works collaboratively with your GP and other healthcare providers to ensure your pain management plan is coordinated and safe.